Dsm-firmenich rises as narrowed down guidance should 'reassure'
Refinitivقراءة أقل من دقيقة
** Shares in dsm-firmenich DSFIR rise around 3.5%
** The Dutch chemicals and fragrance maker narrowed down its FY 2025 adjusted EBIDTA guidance to 2.4 billion euros ($2.75 billion)from "above" 2.4 billion euros previously
** J.P.Morgan says the new guidance is close to the consensus of 2.37 billion euros and should "reassure"
** "The three core businesses continue to show sustained growth despite the fact that the YOY comparison is very challenging," says Equita
** "We continue to believe that the market is overly negative on the stock with multiples close to the lows of the historical range," broker adds
** Up to the previous session's close, shares were down 13.2% YTD
($1 = 0.8737 euros)
قم بتسجيل الدخول أو إنشاء حساب مجاني إلى الأبد لقراءة هذه الأخبار